Revenue
322 thousand USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 321576 USD Source
Annual consolidated revenue for 2026: about USD 3.026M, using the latest reported figures. The previous period, 2025, was about USD 2.662M.
808356 USD
8337454 shares
-66.67% · -16.7 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-14.
Financial data available through: 2026-04-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2.66 million
–
Current period
USD 3.03 million
–
3025538 − 2662105 = 363433 USD
2662105 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source3025538 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 850,746
–
Current period
−USD 37,304
–
-37304 − 850746 = -888050 USD
850746 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source-37304 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 192,774
–
Current period
USD 814,407
–
814407 − 192774 = 621633 USD
192774 USD · 2024-05-01 – 2025-04-30
Inspect prior input Prior source814407 USD · 2025-05-01 – 2026-04-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2017-05-01 – 2018-04-30 | 0 | 48649 Derived | -48649 | -47054 Derived | -1595 | Unavailable | Source
|
| 2019 2018-05-01 – 2019-04-30 | 0 | 71811 Derived | -71811 | 34356 Derived | -106167 | Unavailable | Source
|
| 2020 2019-05-01 – 2020-04-30 | 0 | 72334 Derived | -72334 | 0 Derived | -72334 | Unavailable | Source
|
| 2021 2020-05-01 – 2021-04-30 | 0 | 52094 Derived | -52094 | 0 Derived | -52094 | Unavailable | Source
|
| 2022 2021-05-01 – 2022-04-30 | 120000 | 133367 Derived | -13367 | -153049 Derived | 139682 | Unavailable | Source
|
| 2023 2022-05-01 – 2023-04-30 | 38000 | 62227 Derived | -24227 | 0 Derived | -24227 | Unavailable | Source
|
| 2024 2023-05-01 – 2024-04-30 | 570694 | 365065 Derived | 205629 | 64764 Derived | 140865 | Unavailable | Source
|
| 2025 2024-05-01 – 2025-04-30 | 2662105 | 1453791 Derived | 1208314 | 357568 Derived | 850746 | Unavailable | Source
|
| 2026 2025-05-01 – 2026-04-30 | 3025538 | 3021937 Derived | 3601 | 40905 Derived | -37304 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 0 |
|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 120000 |
|
| 2023 | Revenue | 38000 |
|
| 2024 | Revenue | 570694 |
|
| 2025 | Revenue | 2662105 |
|
| 2026 | Revenue | 3025538 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -68.3% |
|
| 2024 | Year over year | 1,401.8% |
|
| 2025 | Year over year | 366.5% |
|
| 2026 | Year over year | 13.7% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | Not reported |
|
| 2019 | Operating margin | Not reported |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -11.1% |
|
| 2023 | Operating margin | -63.8% |
|
| 2024 | Operating margin | 36% |
|
| 2025 | Operating margin | 45.4% |
|
| 2026 | Operating margin | 0.1% |
|
| 2018 | Net margin | Not reported |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | 116.4% |
|
| 2023 | Net margin | -63.8% |
|
| 2024 | Net margin | 24.7% |
|
| 2025 | Net margin | 32% |
|
| 2026 | Net margin | -1.2% |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
| 2026 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -9295 |
|
| 2019 | Operating cash flow | -49113 |
|
| 2020 | Operating cash flow | -53579 |
|
| 2021 | Operating cash flow | -42286 |
|
| 2022 | Operating cash flow | 4061 |
|
| 2023 | Operating cash flow | -18375 |
|
| 2024 | Operating cash flow | -375880 |
|
| 2025 | Operating cash flow | 192774 |
|
| 2026 | Operating cash flow | 814407 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
| 2026 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 11.7% |
|
| 2019 | Liabilities / assets | Not reported |
|
| 2020 | Liabilities / assets | Not reported |
|
| 2021 | Liabilities / assets | Not reported |
|
| 2022 | Liabilities / assets | 251.4% |
|
| 2023 | Liabilities / assets | 778.4% |
|
| 2024 | Liabilities / assets | 11.5% |
|
| 2025 | Liabilities / assets | 15.4% |
|
| 2026 | Liabilities / assets | 16.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | Not reported |
|
| 2019 | Current assets / current liabilities | 0× |
|
| 2020 | Current assets / current liabilities | 0× |
|
| 2021 | Current assets / current liabilities | 0× |
|
| 2022 | Current assets / current liabilities | 0.4× |
|
| 2023 | Current assets / current liabilities | 0.13× |
|
| 2024 | Current assets / current liabilities | 8.71× |
|
| 2025 | Current assets / current liabilities | 6.49× |
|
| 2026 | Current assets / current liabilities | 6.14× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2017-05-01 – 2018-04-30 | −USD 1,595 Exact valueExact value: -1595 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9,295 Exact valueExact value: -9295 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-05-01 – 2019-04-30 | −USD 106,167 Exact valueExact value: -106167 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49,113 Exact valueExact value: -49113 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-05-01 – 2020-04-30 | −USD 72,334 Exact valueExact value: -72334 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 53,579 Exact valueExact value: -53579 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-05-01 – 2021-04-30 | −USD 52,094 Exact valueExact value: -52094 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 42,286 Exact valueExact value: -42286 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-05-01 – 2022-04-30 | USD 139,682 Exact valueExact value: 139682 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,061 Exact valueExact value: 4061 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-05-01 – 2023-04-30 | −USD 24,227 Exact valueExact value: -24227 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18,375 Exact valueExact value: -18375 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-05-01 – 2024-04-30 | USD 140,865 Exact valueExact value: 140865 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 375,880 Exact valueExact value: -375880 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-05-01 – 2025-04-30 | USD 850,746 Exact valueExact value: 850746 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 192,774 Exact valueExact value: 192774 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-05-01 – 2026-04-30 | −USD 37,304 Exact valueExact value: -37304 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 814,407 Exact valueExact value: 814407 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
43 filings · 2,260 latest values · 2,277 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001699709, 1699709, VNOV, edgar:1699709
Also known as Soldino Group Corp, VITANOVA LIFE SCIENCES CORPORATION, VitaNova Life Sciences Corp, VitaNova Life Sciences Corporation, YIJIA GROUP CORP, YIJIA GROUP CORP., Yijia Group Corp, Yijia Group Corp.